Therapeutics for neonatal brain injury

Pharmacology and Therapeutics

Volumn 120, Issue 1, 2008, Pages 43-53

  Gonzalez, Fernando F ^a   Ferriero, Donna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypoxia; Ischemia; Neonatal stroke; Neurogenesis; Neuroprotection

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 AMINOBENZAMIDE; ACETYLCYSTEINE; ALLOPURINOL; AMPA RECEPTOR; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID; DEFEROXAMINE; DIZOCILPINE; ERYTHROPOIETIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GROWTH FACTOR; KAINIC ACID RECEPTOR; MAGNESIUM SULFATE; MELATONIN; MEMANTINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TOPIRAMATE; VASCULOTROPIN;

BRAIN INJURY; BRAIN METABOLISM; CAUSE OF DEATH; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXCITOTOXICITY; HUMAN; INFLAMMATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; STROKE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BRAIN INJURIES; CELL DEATH; COMBINED MODALITY THERAPY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PREGNANCY; STEM CELL TRANSPLANTATION;

EID: 51649094198     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.07.003     Document Type: Review

References (226)

1. Aher S., and Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006) CD004868
2. Alkan T., Kahveci N., Buyukuysal L., Korfali E., and Ozluk K. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats. Arch Physiol Biochem 109 2 (2001) 135-144
3. Almli L.M., Hamrick S.E., Koshy A.A., Tauber M.G., and Ferriero D.M. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons. Brain Res Dev Brain Res 132 2 (2001) 121-129
4. Aruoma O.I., Halliwell B., Hoey B.M., and Butler J. The antioxidant action of n-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6 6 (1989) 593-597
5. Arvin K.L., Han B.H., Du Y., Lin S.Z., Paul S.M., and Holtzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52 1 (2002) 54-61
6. Azzopardi D., Robertson N.J., Cowan F.M., Rutherford M.A., Rampling M., and Edwards A.D. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 106 4 (2000) 684-694
7. Bagnard D., Vaillant C., Khuth S.T., Dufay N., Lohrum M., Puschel A.W., et al. Semaphorin 3a-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 21 10 (2001) 3332-3341
8. Ballard R.A., Truog W.E., Cnaan A., Martin R.J., Ballard P.L., Merrill J.D., et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 4 (2006) 343-353
9. Baud O., Li J., Zhang Y., Neve R.L., Volpe J.J., and Rosenberg P.A. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci 20 7 (2004) 1713-1726
10. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 5 Pt 1 (1996) C1424-1437
11. Benders M.J., Bos A.F., Rademaker C.M., Rijken M., Torrance H.L., Groenendaal F., et al. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 91 3 (2006) F163-165
12. Benito C., Romero J.P., Tolon R.M., Clemente D., Docagne F., Hillard C.J., et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27 9 (2007) 2396-2402
13. Berger R.P., Beers S.R., Richichi R., Wiesman D., and Adelson P.D. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24 12 (2007) 1793-1801
14. Bergeron M., Gidday J.M., Yu A.Y., Semenza G.L., Ferriero D.M., and Sharp F.R. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48 3 (2000) 285-296
15. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19 6 (1999) 643-651
16. Black S.M., Bedolli M.A., Martinez S., Bristow J.D., Ferriero D.M., and Soifer S.J. Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol Dis 2 3 (1995) 145-155
17. Blomgren K., Zhu C., Wang X., Karlsson J.O., Leverin A.L., Bahr B.A., et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?. J Biol Chem 276 13 (2001) 10191-10198
18. Bona E., Hagberg H., Loberg E.M., Bagenholm R., and Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 43 6 (1998) 738-745
19. Boucher J.L., Moali C., and Tenu J.P. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for l-arginine utilization. Cell Mol Life Sci 55 8-9 (1999) 1015-1028
20. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97 19 (2000) 10526-10531
21. Brion L.P., Bell E.F., and Raghuveer T.S. Vitamin e supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 4 (2003) CD003665
22. Buonocore G., Perrone S., and Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 79 3-4 (2001) 180-186
23. Busto R., Globus M.Y., Dietrich W.D., Martinez E., Valdes I., and Ginsberg M.D. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 20 7 (1989) 904-910
24. Cai Z., Lin S., Fan L.W., Pang Y., and Rhodes P.G. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137 2 (2006) 425-435
25. Capone C., Frigerio S., Fumagalli S., Gelati M., Principato M.C., Storini C., et al. Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS ONE 2 4 (2007) e373
26. Carloni S., Perrone S., Buonocore G., Longini M., Proietti F., and Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 44 2 (2008) 157-164
27. Carty M.L., Wixey J.A., Colditz P.B., and Buller K.M. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: A comparison of two different dose regimens. Int J Dev Neurosci 26 5 (2008) 477-485
28. Chang Y.S., Mu D., Wendland M., Sheldon R.A., Vexler Z.S., McQuillen P.S., et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58 1 (2005) 106-111
29. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97 6 (2006) 1611-1626
30. Chen H.S., Wang Y.F., Rayudu P.V., Edgecomb P., Neill J.C., Segal M.M., et al. Neuroprotective concentrations of the n-methyl-d-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86 4 (1998) 1121-1132
31. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6 7 (2000) 797-801
32. Cheng E.T., Utley D.S., Ho P.R., Tarn D.M., Coan G.M., Verity A.N., et al. Functional recovery of transected nerves treated with systemic BDNF and CNTF. Microsurgery 18 1 (1998) 35-41
33. Cheng Y., Gidday J.M., Yan Q., Shah A.R., and Holtzman D.M. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 41 4 (1997) 521-529
34. Chiarugi A., and Moskowitz M.A. Cell biology. PARP-1-a perpetrator of apoptotic cell death?. Science 297 5579 (2002) 200-201
35. Choi Y., Kim H.S., Shin K.Y., Kim E.M., Kim M., Kim H.S., et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32 11 (2007) 2393-2404
36. Chong Z.Z., Kang J.Q., and Maiese K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res 11 6 (2002) 863-871
37. Clancy R.R., McGaurn S.A., Goin J.E., Hirtz D.G., Norwood W.I., Gaynor J.W., et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 108 1 (2001) 61-70
38. Crowther C.A., Hiller J.E., Doyle L.W., and Haslam R.R. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290 20 (2003) 2669-2676
39. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11 3 (2001) 327-335
40. Dammann O., Kuban K.C., and Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 8 1 (2002) 46-50
41. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., and Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13 6 (1993) 2651-2661
42. Demers E.J., McPherson R.J., and Juul S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58 2 (2005) 297-301
43. Deng W., Wang H., Rosenberg P.A., Volpe J.J., and Jensen F.E. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A 101 20 (2004) 7751-7756
44. Dietrich W.D., Busto R., Alonso O., Globus M.Y., and Ginsberg M.D. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 13 4 (1993) 541-549
45. Dilenge M.E., Majnemer A., and Shevell M.I. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol 16 11 (2001) 781-792
46. Dinse A., Fohr K.J., Georgieff M., Beyer C., Bulling A., and Weigt H.U. Xenon reduces glutamate-, ampa-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth 94 4 (2005) 479-485
47. Dommergues M.A., Patkai J., Renauld J.C., Evrard P., and Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47 1 (2000) 54-63
48. Dommergues M.A., Plaisant F., Verney C., and Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 3 (2003) 619-628
49. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98 25 (2001) 14669-14674
50. Ducrocq S., Benjelloun N., Plotkine M., Ben-Ari Y., and Charriaut-Marlangue C. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 74 6 (2000) 2504-2511
51. Edwards A.D., Yue X., Squier M.V., Thoresen M., Cady E.B., Penrice J., et al. Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 217 3 (1995) 1193-1199
52. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 8 (2002) 495-505
53. Ehrenreich H., Hinze-Selch D., Stawicki S., Aust C., Knolle-Veentjer S., Wilms S., et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12 2 (2007) 206-220
54. Eicher D.J., Wagner C.L., Katikaneni L.P., Hulsey T.C., Bass W.T., Kaufman D.A., et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 32 1 (2005) 11-17
55. Ergenekon E., Gucuyener K., Erbas D., Suheyl Ezgu F., and Atalay Y. Cerebrospinal fluid and serum nitric oxide levels in asphyxiated newborns. Biol Neonate 76 4 (1999) 200-206
56. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., et al. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 82 1 (2005) 71-82
57. Feng Y., Fratkin J.D., and LeBlanc M.H. Inhibiting caspase-8 after injury reduces hypoxic-ischemic brain injury in the newborn rat. Eur J Pharmacol 481 2-3 (2003) 169-173
58. Fern R., and Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20 1 (2000) 34-42
59. Fernandez-Lopez D., Pazos M.R., Tolon R.M., Moro M.A., Romero J., Lizasoain I., et al. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. Pediatr Res 62 3 (2007) 255-260
60. Ferriero D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 23 3 (2001) 198-202
61. Ferriero D.M. Neonatal brain injury. N Engl J Med 351 19 (2004) 1985-1995
62. Ferriero D.M., Holtzman D.M., Black S.M., and Sheldon R.A. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3 1 (1996) 64-71
63. Ferriero D.M., Sheldon R.A., Black S.M., and Chuai J. Selective destruction of nitric oxide synthase neurons with quisqualate reduces damage after hypoxia-ischemia in the neonatal rat. Pediatr Res 38 6 (1995) 912-918
64. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A., et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24 18 (2004) 4412-4420
65. Forstreuter F., Lucius R., and Mentlein R. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132 1-2 (2002) 93-98
66. Fox C., Dingman A., Derugin N., Wendland M.F., Manabat C., Ji S., et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25 9 (2005) 1138-1149
67. 2-.), superoxide dismutases, and related matters. J Biol Chem 272 30 (1997) 18515-18517
68. Geddes R., Vannucci R.C., and Vannucci S.J. Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. Dev Neurosci 23 3 (2001) 180-185
69. Gidday J.M., Fitzgibbons J.C., Shah A.R., and Park T.S. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168 1-2 (1994) 221-224
70. Gitto E., Reiter R.J., Cordaro S.P., La Rosa M., Chiurazzi P., Trimarchi G., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: Beneficial effects of melatonin. Am J Perinatol 21 4 (2004) 209-216
71. Gitto E., Reiter R.J., Sabatino G., Buonocore G., Romeo C., Gitto P., et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: Improvement with melatonin treatment. J Pineal Res 39 3 (2005) 287-293
72. Globus M.Y., Alonso O., Dietrich W.D., Busto R., and Ginsberg M.D. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem 65 4 (1995) 1704-1711
73. Gluckman P.D., Wyatt J.S., Azzopardi D., Ballard R., Edwards A.D., Ferriero D.M., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 365 9460 (2005) 663-670
74. Gonzalez F.F., McQuillen P., Mu D., Chang Y., Wendland M., Vexler Z., et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29 4-5 (2007) 321-330
75. Gressens P., and Luton D. Fetal MRI: obstetrical and neurological perspectives. Pediatr Radiol 34 9 (2004) 682-684
76. Groenendaal F., Rademaker C.M., Toet M.C., and de Vries L.S. Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr 91 10 (2002) 1073-1077
77. Groenendaal F., Vles J., Lammers H., De Vente J., Smit D., and Nikkels P.G. Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia. Neonatology 93 1 (2008) 1-6
78. Gruss M., Bushell T.J., Bright D.P., Lieb W.R., Mathie A., and Franks N.P. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65 2 (2004) 443-452
79. Gucuyener K., Atalay Y., Aral Y.Z., Hasanoglu A., Turkyilmaz C., and Biberoglu G. Excitatory amino acids and taurine levels in cerebrospinal fluid of hypoxic ischemic encephalopathy in newborn. Clin Neurol Neurosurg 101 3 (1999) 171-174
80. Gunn A.J., Gunn T.R., de Haan H.H., Williams C.E., and Gluckman P.D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 99 2 (1997) 248-256
81. Gunn A.J., Gluckman P.D., and Gunn T.R. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 102 4 Pt 1 (1998) 885-892
82. Gunn A.J., Gunn T.R., Gunning M.I., Williams C.E., and Gluckman P.D. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics 102 5 (1998) 1098-1106
83. Gustavsson M., Anderson M.F., Mallard C., and Hagberg H. Hypoxic preconditioning confers long-term reduction of brain injury and improvement of neurological ability in immature rats. Pediatr Res 57 2 (2005) 305-309
84. Guzman R., Uchida N., Bliss T.M., He D., Christopherson K.K., Stellwagen D., et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 104 24 (2007) 10211-10216
85. Hagberg B., Hagberg G., Olow I., and von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 85 8 (1996) 954-960
86. Hagberg H., Wilson M.A., Matsushita H., Zhu C., Lange M., Gustavsson M., et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 90 5 (2004) 1068-1075
87. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 31 4 (1999) 261-272
88. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 97 6 (2006) 1634-1658
89. Hamrick S.E., McQuillen P.S., Jiang X., Mu D., Madan A., and Ferriero D.M. A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett 379 2 (2005) 96-100
90. Han B.H., Xu D., Choi J., Han Y., Xanthoudakis S., Roy S., et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 277 33 (2002) 30128-30136
91. Harding D.R., Dhamrait S., Whitelaw A., Humphries S.E., Marlow N., and Montgomery H.E. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth?. Pediatrics 114 4 (2004) 941-947
92. Harrigan M.R., Ennis S.R., Sullivan S.E., and Keep R.F. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wien) 145 1 (2003) 49-53
93. Hayashi T., Abe K., and Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18 8 (1998) 887-895
94. Haynes R.L., Baud O., Li J., Kinney H.C., Volpe J.J., and Folkerth D.R. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15 3 (2005) 225-233
95. Hellstrom-Westas L., and Rosen I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 11 6 (2006) 503-511
96. Hicks A.U., Hewlett K., Windle V., Chernenko G., Ploughman M., Jolkkonen J., et al. Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience 146 1 (2007) 31-40
97. Higuchi Y., Hattori H., Kume T., Tsuji M., Akaike A., and Furusho K. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 342 1 (1998) 47-49
98. Hobbs C., Thoresen M., Tucker A., Aquilina K., Chakkarapani E., and Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 39 4 (2008) 1307-1313
99. Hoehn M., Kustermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99 25 (2002) 16267-16272
100. Holtzman D.M., Sheldon R.A., Jaffe W., Cheng Y., and Ferriero D.M. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 39 1 (1996) 114-122
101. Hu B.R., Liu C.L., Ouyang Y., Blomgren K., and Siesjo B.K. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20 9 (2000) 1294-1300
102. Husson I., Rangon C.M., Lelievre V., Bemelmans A.P., Sachs P., Mallet J., et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15 3 (2005) 250-261
103. Iadecola C., Zhang F., Casey R., Nagayama M., and Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17 23 (1997) 9157-9164
104. Ikonomidou C., and Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol 1 6 (2002) 383-386
105. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 52 (2004) 18117-18122
106. Ishida A., Trescher W.H., Lange M.S., and Johnston M.V. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 23 5 (2001) 349-354
107. Jatana M., Singh I., Singh A.K., and Jenkins D. Combination of systemic hypothermia and n-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 59 5 (2006) 684-689
108. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., and Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 99 18 (2002) 11946-11950
109. Johnston B.M., Mallard E.C., Williams C.E., and Gluckman P.D. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 97 2 (1996) 300-308
110. Juul, S. E., McPherson, R. J., Bauer, L. A., Ledbetter, K. J., Gleason, C. A., & Maycock, D. E., (in press). A phase I/II trial of high dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics.
111. Juul S.E., Yachnis A.T., Rojiani A.M., and Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2 2 (1999) 148-158
112. Karadottir R., Cavelier P., Bergersen L.H., and Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438 7071 (2005) 1162-1166
113. Kawamura M., Nakajima W., Ishida A., Ohmura A., Miura S., and Takada G. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037 1-2 (2005) 59-69
114. Kerk J., Dordelmann M., Bartels D.B., Brinkhaus M.J., Dammann C.E., Dork T., et al. Multiplex measurement of cytokine/receptor gene polymorphisms and interaction between interleukin-10 (- 1082) genotype and chorioamnionitis in extreme preterm delivery. J Soc Gynecol Investig 13 5 (2006) 350-356
115. Khan J.Y., and Black S.M. Developmental changes in murine brain antioxidant enzymes. Pediatr Res 54 1 (2003) 77-82
116. Khan M., Sekhon B., Jatana M., Giri S., Gilg A.G., Sekhon C., et al. Administration of n-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76 4 (2004) 519-527
117. Khashaba M.T., Shouman B.O., Shaltout A.A., Al-Marsafawy H.M., Abdel-Aziz M.M., Patel K., et al. Excitatory amino acids and magnesium sulfate in neonatal asphyxia. Brain Dev 28 6 (2006) 375-379
118. Kinney H.C., and Back S.A. Human oligodendroglial development: relationship to periventricular leukomalacia. Semin Pediatr Neurol 5 3 (1998) 180-189
119. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5 5 (2005) 400-411
120. Koh P.O. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of PBAD from 14-3-3. J Pineal Res 44 1 (2008) 101-106
121. Krum J.M., and Rosenstein J.M. VEGF MRNA and its receptor FLT-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 154 1 (1998) 57-65
122. Kukley M., Capetillo-Zarate E., and Dietrich D. Vesicular glutamate release from axons in white matter. Nat Neurosci 10 3 (2007) 311-320
123. Kumral A., Uysal N., Tugyan K., Sonmez A., Yilmaz O., Gokmen N., et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153 1 (2004) 77-86
124. Lafemina M.J., Sheldon R.A., and Ferriero D.M. Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr Res 59 5 (2006) 680-683
125. Laptook A.R., and Corbett R.J. The effects of temperature on hypoxic-ischemic brain injury. Clin Perinatol 29 4 (2002) 623-649 vi
126. Laptook A.R., Corbett R.J., Sterett R., Burns D.K., Garcia D., and Tollefsbol G. Modest hypothermia provides partial neuroprotection when used for immediate resuscitation after brain ischemia. Pediatr Res 42 1 (1997) 17-23
127. Laptook A.R., Corbett R.J., Sterett R., Burns D.K., Tollefsbol G., and Garcia D. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res 35 4 Pt 1 (1994) 436-442
128. Levene M., Blennow M., Whitelaw A., Hanko E., Fellman V., and Hartley R. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed 73 3 (1995) F174-177
129. Liu Y., Barks J.D., Xu G., and Silverstein F.S. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35 6 (2004) 1460-1465
130. Lok J., and Martin L.J. Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J Neurotrauma 19 7 (2002) 815-828
131. Lu D., Mahmood A., Qu C., Goussev A., Schallert T., and Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22 9 (2005) 1011-1017
132. Ma D., Hossain M., Chow A., Arshad M., Battson R.M., Sanders R.D., et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58 2 (2005) 182-193
133. Ma J., and Zhang G.Y. Lithium reduced n-methyl-d-aspartate receptor subunit 2a tyrosine phosphorylation and its interactions with SRC and FYN mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett 348 3 (2003) 185-189
134. MacDonald J.F., Jackson M.F., and Beazely M.A. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 18 1-2 (2006) 71-84
135. Machado L.S., Kozak A., Ergul A., Hess D.C., Borlongan C.V., and Fagan S.C. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 7 (2006) 56
136. Manning S., Talos D., Zhou C., Selip D., Park H.K., Park C.J., et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28 26 (2008) 6670-6678
137. Marks K.A., Mallard C.E., Roberts I., Williams C.E., Gluckman P.D., and Edwards A.D. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res 40 2 (1996) 185-191
138. Marret S., Gressens P., Gadisseux J.F., and Evrard P. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 37 6 (1995) 473-484
139. Maurer M.H., Tripps W.K., Feldmann Jr. R.E., and Kuschinsky W. Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci Lett 344 3 (2003) 165-168
140. McPherson R.J., and Juul S.E. High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine. Growth Horm IGF Res 17 5 (2007) 424-430
141. McQuillen P.S., and Ferriero D.M. Selective vulnerability in the developing central nervous system. Pediatr Neurol 30 4 (2004) 227-235
142. Mechoulam R., Panikashvili D., and Shohami E. Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 8 2 (2002) 58-61
143. Miller S.P., Latal B., Clark H., Barnwell A., Glidden D., Barkovich A.J., et al. Clinical signs predict 30-month neurodevelopmental outcome after neonatal encephalopathy. Am J Obstet Gynecol 190 1 (2004) 93-99
144. Miller S.P., Ramaswamy V., Michelson D., Barkovich A.J., Holshouser B., Wycliffe N., et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 146 4 (2005) 453-460
145. Modo M., Mellodew K., Cash D., Fraser S.E., Meade T.J., Price J., et al. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21 1 (2004) 311-317
146. Mu D., Chang Y.S., Vexler Z.S., and Ferriero D.M. Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195 2 (2005) 407-415
147. Mu D., Jiang X., Sheldon R.A., Fox C.K., Hamrick S.E., Vexler Z.S., et al. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 14 3 (2003) 524-534
148. Mueller F.J., Serobyan N., Schraufstatter I.U., DiScipio R., Wakeman D., Loring J.F., et al. Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 24 11 (2006) 2367-2372
149. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19 8 (1999) 2987-2995
150. Nelson K.B., and Lynch J.K. Stroke in newborn infants. Lancet Neurol 3 3 (2004) 150-158
151. Noh M.R., Kim S.K., Sun W., Park S.K., Choi H.C., Lim J.H., et al. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201 2 (2006) 470-478
152. Northington F.J., Ferriero D.M., Graham E.M., Traystman R.J., and Martin L.J. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 8 2 (2001) 207-219
153. Northington F.J., Graham E.M., and Martin L.J. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res Brain Res Rev 50 2 (2005) 244-257
154. Nunez J., Yang Z., Jiang Y., Grandys T., Mark I., and Levison S.W. 17beta-estradiol protects the neonatal brain from hypoxia-ischemia. Exp Neurol 208 2 (2007) 269-276
155. Obenaus A., Robbins M., Blanco G., Galloway N.R., Snissarenko E., Gillard E., et al. Multi-modal magnetic resonance imaging alterations in two rat models of mild neurotrauma. J Neurotrauma 24 7 (2007) 1147-1160
156. Olney J.W. Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3 1 (2003) 101-109
157. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Meozzi P.A., Myers L., et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS ONE 3 2 (2008) e1640
158. Ostwald K., Hagberg H., Andine P., and Karlsson J.O. Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res 630 1-2 (1993) 289-294
159. Paintlia M.K., Paintlia A.S., Barbosa E., Singh I., and Singh A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 78 3 (2004) 347-361
160. Palmer C., Roberts R.L., and Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25 5 (1994) 1039-1045
161. Palmer C., Towfighi J., Roberts R.L., and Heitjan D.F. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 33 4 Pt 1 (1993) 405-411
162. Palmer T.D., Willhoite A.R., and Gage F.H. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425 4 (2000) 479-494
163. Pang Y., Zheng B., Fan L.W., Rhodes P.G., and Cai Z. IGF-1 protects oligodendrocyte progenitors against tnfalpha-induced damage by activation of PI3K/AKT and interruption of the mitochondrial apoptotic pathway. Glia 55 11 (2007) 1099-1107
164. Panikashvili D., Shein N.A., Mechoulam R., Trembovler V., Kohen R., Alexandrovich A., et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits MRNA expression of proinflammatory cytokines. Neurobiol Dis 22 2 (2006) 257-264
165. Park K.I., Hack M.A., Ourednik J., Yandava B., Flax J.D., Stieg P.E., et al. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: Evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp Neurol 199 1 (2006) 156-178
166. Park K.I., Himes B.T., Stieg P.E., Tessler A., Fischer I., and Snyder E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 199 1 (2006) 179-190
167. Park K.I., Teng Y.D., and Snyder E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20 11 (2002) 1111-1117
168. Perlman J.M. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther 28 9 (2006) 1353-1365
169. Plane J.M., Liu R., Wang T.W., Silverstein F.S., and Parent J.M. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis 16 3 (2004) 585-595
170. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., and Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51 2 (2002) 215-223
171. Portera-Cailliau C., Price D.L., and Martin L.J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 378 1 (1997) 88-104
172. Pruzanski W., Greenwald R.A., Street I.P., Laliberte F., Stefanski E., and Vadas P. Inhibition of enzymatic activity of phospholipases a2 by minocycline and doxycycline. Biochem Pharmacol 44 6 (1992) 1165-1170
173. Raab S., Beck H., Gaumann A., Yuce A., Gerber H.P., Plate K., et al. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 91 3 (2004) 595-605
174. Ran R., Xu H., Lu A., Bernaudin M., and Sharp F.R. Hypoxia preconditioning in the brain. Dev Neurosci 27 2-4 (2005) 87-92
175. Rice H.E., Hsu E.W., Sheng H., Evenson D.A., Freemerman A.J., Safford K.M., et al. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. AJR Am J Roentgenol 188 4 (2007) 1101-1108
176. Rossi D.J., Oshima T., and Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 6767 (2000) 316-321
177. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95 8 (1998) 4635-4640
178. Salter M.G., and Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438 7071 (2005) 1167-1171
179. Sarco D.P., Becker J., Palmer C., Sheldon R.A., and Ferriero D.M. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci Lett 282 1-2 (2000) 113-116
180. Scarabelli T.M., Stephanou A., Pasini E., Gitti G., Townsend P., Lawrence K., et al. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to SMAC/DIABLO, and reduces the mitochondrial leakage of cytochrome c and SMAC/DIABLO. J Am Coll Cardiol 43 5 (2004) 865-874
181. Schreiber M.D., Gin-Mestan K., Marks J.D., Huo D., Lee G., and Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 22 (2003) 2099-2107
182. Sekhon B., Sekhon C., Khan M., Patel S.J., Singh I., and Singh A.K. N-acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971 1 (2003) 1-8
183. Sfaello I., Baud O., Arzimanoglou A., and Gressens P. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20 3 (2005) 837-848
184. Shankaran S., Laptook A., Wright L.L., Ehrenkranz R.A., Donovan E.F., Fanaroff A.A., et al. Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics 110 2 Pt 1 (2002) 377-385
185. Shankaran S., Laptook A.R., Ehrenkranz R.A., Tyson J.E., McDonald S.A., Donovan E.F., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 15 (2005) 1574-1584
186. Sharp F.R., and Bernaudin M. Hif1 and oxygen sensing in the brain. Nat Rev Neurosci 5 6 (2004) 437-448
187. Sheldon R.A., Aminoff A., Lee C.L., Christen S., and Ferriero D.M. Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain. Pediatr Res 61 6 (2007) 666-670
188. Sheldon R.A., Jiang X., Francisco C., Christen S., Vexler Z.S., Tauber M.G., et al. Manipulation of antioxidant pathways in neonatal murine brain. Pediatr Res 56 4 (2004) 656-662
189. Shellhaas R.A., Soaita A.I., and Clancy R.R. Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics 120 4 (2007) 770-777
190. Shingo T., Sorokan S.T., Shimazaki T., and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21 24 (2001) 9733-9743
191. Sola A., Rogido M., Lee B.H., Genetta T., and Wen T.C. Erythropoietin after focal cerebral ischemia activates the janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 57 4 (2005) 481-487
192. Sola A., Wen T.C., Hamrick S.E., and Ferriero D.M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr Res 57 5 Pt 2 (2005) 110R-117R
193. 4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reprod Sci 14 7 (2007) 667-677
194. Stirling D.P., Koochesfahani K.M., Steeves J.D., and Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 11 4 (2005) 308-322
195. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 8 (2005) 1672-1678
196. Talos D.M., Follett P.L., Folkerth R.D., Fishman R.E., Trachtenberg F.L., Volpe J.J., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 497 1 (2006) 61-77
197. Taylor D.L., Edwards A.D., and Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol 9 1 (1999) 93-117
198. Thoresen M. Cooling the newborn after asphyxia - physiological and experimental background and its clinical use. Semin Neonatol 5 1 (2000) 61-73
199. Thoresen M., Penrice J., Lorek A., Cady E.B., Wylezinska M., Kirkbride V., et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 37 5 (1995) 667-670
200. Thoresen M., and Whitelaw A. Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy. Pediatrics 106 1 Pt 1 (2000) 92-99
201. Towfighi J., Housman C., Heitjan D.F., Vannucci R.C., and Yager J.Y. The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. Acta Neuropathol 87 6 (1994) 598-604
202. Trescher W.H., Ishiwa S., and Johnston M.V. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 19 5 (1997) 326-338
203. Tsuji M., Wilson M.A., Lange M.S., and Johnston M.V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189 1 (2004) 58-65
204. Turkyilmaz C., Turkyilmaz Z., Atalay Y., Soylemezoglu F., and Celasun B. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res 955 1-2 (2002) 133-137
205. van den Tweel E.R., van Bel F., Kavelaars A., Peeters-Scholte C.M., Haumann J., Nijboer C.H., et al. Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats. J Cereb Blood Flow Metab 25 1 (2005) 67-74
206. van der Stelt M., Veldhuis W.B., van Haaften G.W., Fezza F., Bisogno T., Bar P.R., et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 21 22 (2001) 8765-8771
207. Van Leeuwen G.M., Hand J.W., Lagendijk J.J., Azzopardi D.V., and Edwards A.D. Numerical modeling of temperature distributions within the neonatal head. Pediatr Res 48 3 (2000) 351-356
208. Vannucci R.C., Towfighi J., and Vannucci S.J. Hypoxic preconditioning and hypoxic-ischemic brain damage in the immature rat: pathologic and metabolic correlates. J Neurochem 71 3 (1998) 1215-1220
209. Vannucci S.J., and Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 207 Pt 18 (2004) 3149-3154
210. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198 6 (2003) 971-975
211. Volbracht C., van Beek J., Zhu C., Blomgren K., and Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci 23 10 (2006) 2611-2622
212. Volpe J.J. Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention. Clin Perinatol 24 3 (1997) 567-587
213. Wang C.X., Yang T., and Shuaib A. Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res 963 1-2 (2003) 327-329
214. Wang J., Wei Q., Wang C.Y., Hill W.D., Hess D.C., and Dong Z. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279 19 (2004) 19948-19954
215. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 7 (2004) 1732-1737
216. Wasserman J.K., Zhu X., and Schlichter L.C. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res 1180 (2007) 140-154
217. Wen T.C., Rogido M., Peng H., Genetta T., Moore J., and Sola A. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 139 3 (2006) 803-811
218. Wu Y.W., Backstrand K.H., Zhao S., Fullerton H.J., and Johnston S.C. Declining diagnosis of birth asphyxia in California: 1991-2000. Pediatrics 114 6 (2004) 1584-1590
219. Wu Y.W., and Colford Jr. J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. Jama 284 11 (2000) 1417-1424
220. Wu Y.W., Escobar G.J., Grether J.K., Croen L.A., Greene J.D., and Newman T.B. Chorioamnionitis and cerebral palsy in term and near-term infants. Jama 290 20 (2003) 2677-2684
221. Wyatt J.S., Gluckman P.D., Liu P.Y., Azzopardi D., Ballard R., Edwards A.D., et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 119 5 (2007) 912-921
222. Yang X., and Cepko C.L. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16 19 (1996) 6089-6099
223. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96 23 (1999) 13496-13500
224. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14 5 (2005) 207-221
225. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106 7 (2000) 829-838
226. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 6884 (2002) 74-78